Consequently, the reduction of protein levels impacts the splicing isoforms of YT521 cancer-related targets, such as BRCA2 and PGR. Nevertheless, further analyses are needed to assess the impact of YT521 knockdown on key hallmarks of cancer. The gene discussed is BRCA2; the disease is cancer.